Cash & equivalents decreased 31.5%
Cash & equivalents changed -31.5% from the comparable as-filed period.
$300.5M→$205.9M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PCRX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Debt decreased 37.4%
Debt changed -37.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$580.5M→$363.1M4 prior comparisons
Net income increased 196.0%
Net income changed +196.0% from the comparable as-filed period.
-$4.8M→$4.7M3 prior comparisons
Operating income decreased 49.8%
Operating income changed -49.8% from the comparable as-filed period.
$8.5M→$4.3M3 prior comparisons
Operating margin moved 248 bp lower
Operating margin changed -248 basis points from the comparable as-filed period.
4.69%→2.22%1 prior comparisons
Revenue increased 6.2%
Revenue changed +6.2% from the comparable as-filed period.
$181.1M→$192.4M3 prior comparisons
Inventory decreased 9.2%
Inventory changed -9.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$148.2M→$134.6M4 prior comparisons
Research & development increased 7.2%
Research & development changed +7.2% from the comparable as-filed period.
$28.2M→$30.2M3 prior comparisons
Selling, general & administrative increased 3.6%
Selling, general & administrative changed +3.6% from the comparable as-filed period.
$88.6M→$91.8M3 prior comparisons
Stock-based compensation decreased 3.3%
Stock-based compensation changed -3.3% from the comparable as-filed period.
$15.5M→$15.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.